Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanobac enlists Lebanese distributor for Middle East CNP (calcifying nanoparticles) sales:

This article was originally published in Clinica

Executive Summary

Nanobac Pharmaceuticals, the Tampa, Florida-based specialist in nanobacteria-based diagnostics, has appointed Diagnostic Products Corporation Lebanon (DPCL) as its exclusive product distributor for the Middle East region. DPCL will sell Nanobac's CE-marked tests for calcifying nanoparticles (CNPs) in 11 countries, including Lebanon, Saudi Arabia, Syria, Jordan, Iraq, Kuwait, Bahrain and Egypt. The distributor is not affiliated to the US IVD company DPC that is now part of Siemens Medical Solutions Diagnostics. CNPs form a calcium phosphate coating identical to harmful deposits found in diseases such as atherosclerosis, kidney stones, prostatitis, breast cancer and ovarian cancer.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel